Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 3, 2016
Pharmacy Choice - News - Over-the-Counter Drugs - December 3, 2016

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 34     Next >>     Go To Page:

12/3/16 - Nutra Pharma Announces Infomercial Campaign for Pet Pain-Away
By a News Reporter-Staff News Editor at Marketing Weekly News Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced that DEG..
12/2/16 - Pivotal Therapeutics Receives Statement Of Claim and Files Statement Of Defence and Counterclaim Against Crossover Healthcare Fund, LLC
Woodbridge, Ontario/ TheNewswire/ December 1, 2016- Pivotal Therapeutics Inc.,, a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that on October 25, 2016 it received a Statement of Claim from Crossover Healthcare Fund, LLC which was filed in the Ontario Superior Cour
12/2/16 - Senate Publishes 50 Executive Communications from Obama Administration on Dec. 1
A communication from the Executive Analyst, Department of Health and Human Services, transmitting, pursuant to law, a report relative to a vacancy in the position of Commissioner, Administration on Native Americans, Department of Health and Human Services, received in the Office of the President of the Senate on November 30, 2016; to the Committee
12/2/16 - Sunovion to Present Data on Latuda (lurasidone HCl) and Novel Investigational Psychotropic SEP-363856 at the 55th Annual Meeting of the American College of Neuropsychopharmacology
Sunovion Pharmaceuticals Inc. will present four research posters on Latuda and two research posters on novel investigational psychotropic SEP-363856 at the 55 th Annual Meeting of the American College of Neuropsychopharmacology, being held December 4-8 in Hollywood, Florida. Poster M166: A Phase 1 Open Label Safety and Tolerability Study of...
12/2/16 - TCM keeps astronauts healthy [China Daily: Africa Weekly]
It was developed by China's leading over-the-counter pharmaceutical company, Jiangzhong Group, to enhance the astronauts' immunity during their training and space trips. In the long run, the group plans to make the product available to retailing distribution channels, so that consumers can use it to enhance their health, said Zhong Hongguang, chair
12/1/16 - Akers Biosciences Signs Distribution Agreement with First Check Diagnostics for Rapid Cholesterol Test
Akers Biosciences, Inc., a developer of rapid health information technologies, has signed a distribution agreement with First Check Diagnostics, LLC, the major global diagnostic device and service provider, to serve as the exclusive distributor of the Company's rapid cholesterol self-test in the United States under their "First Check" brand.
12/1/16 - BioPharmX Poster at ASCB Annual Meeting to Show Topical Minocycline Has Potential to Deliver Non-Antibiotic Benefits
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, will share research findings this week that suggest topical minocycline fights P. acnes- induced inflammation in human keratinocytes. The data will be shared in a poster presentation titled "Effects of minocycline against Propionibacterium ac
12/1/16 - Inland Empire Health Plan Selects Mirixa for its Innovative Pharmacy Home Program [UMCI News]
-Mirixa Corporation, the leading provider of medication-related services to health plans and PBMs, announced that Inland Empire Health Plan has selected Mirixa Corporation and the MirixaPro platform to administer medication therapy management services for the IEHP Pharmacy Home Program. The IEHP Pharmacy Home program is one of the first large-scale
12/1/16 - Innovus Pharma Launches its Clinically Proven UriVarx? Product for Bladder Health Through its Beyond Human Sales and Marketing Platform in the United States
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced the launch of UriVarx? in the U.S. UriVarx? is clinically proven to reduce urinary u
12/1/16 - MonoSol Rx Receives FDA Orphan Drug Designation for Diazepam Buccal Soluble Film to Treat Acute Repetitive Seizures [Khaleej Times (United Arab Emirates)]
-MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to Diazepam Buccal Soluble Film for the treatment of Acute Repetitive Seizures. Securing Orphan Drug.
12/1/16 - Technical Reports on Generic Drugs Stocks Mylan, Horizon Pharma, Allergan, and Catalent
Equities in today's lineup are: Mylan N.V., Horizon Pharma PLC, Allergan PLC, and Catalent Inc.. Shares in Hertfordshire, the UK- based Mylan N.V. ended Wednesday's session at $36.61, rising 1.53% from the last trading session. On November 18 th, 2016, research firm Mizuho reiterated its' Buy' rating on the Company's stock with a decrease of the ta
11/30/16 - FDA changes coming for livestock owners
COLUMBIA Livestock owners across Missouri are encouraged to prepare for Food and Drug Administration rule changes on antibiotics that will go into effect Jan. 1. Craig Payne, director of veterinary medical extension at the University of Missouri, said there are two main changes. The FDA created a list of antimicrobials in 2003 that are important in
11/30/16 - Inland Empire Health Plan Selects Mirixa for its Innovative Pharmacy Home Program
Mirixa Corporation, the leading provider of medication-related services to health plans and PBMs, announced that Inland Empire Health Plan has selected Mirixa Corporation and the MirixaPro platform to administer medication therapy management services for the IEHP Pharmacy Home Program. The IEHP Pharmacy Home program is one of the first large-scale.
11/30/16 - Innovus Pharma Signs $2 Million a Year Exclusive License and Distribution Agreement with JH Co. LTD for Zestra for Female Sexual Arousal in South Korea [Financial Mirror (Cyprus)]
Innovus Pharma Signs $2 Million a Year Exclusive License and Distribution Agreement with J&H Co. LTD for Zestra for Female Sexual Arousal in South Korea. SAN DIEGO Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care product
11/30/16 - MonoSol Rx Receives FDA Orphan Drug Designation for Diazepam Buccal Soluble Film to Treat Acute Repetitive Seizures
Securing Orphan Drug Designation from the FDA s Office of Orphan Products Development is a significant milestone for MonoSol Rx, said Keith Kendall, CEO of MonoSol Rx. Diazepam is well established as an effective treatment for ARS, but oral administration is challenging given the likelihood that a patient experiencing a seizure will hav
11/30/16 - PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November23, 2016, Provectus Biopharmaceuticals, Inc. (the Company) receiv
11/30/16 - WATERMARK GROUP, INC. (OTCMKTS:WMHH) Files An 8-K Entry into a Material Definitive Agreement
WATERMARK GROUP, INC. (OTCMKTS:WMHH) Files An 8-K Entry into a Material Definitive Agreement Item 1.01 Entry into a Material Definitive Agreement. The disclosure in Item 2.01 below is incorporated by reference herein. Item 2.01 Completion of Acquisition or Disposition of Assets. On October 13, 2016, we entered into an exclusive license agreement (t
11/29/16 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Superimposed Text in...
Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Section 1701 of the Public Health Service Act authorizes the FDA to conduct research relating to healt
11/29/16 - Innovus Pharma Signs $2 Million a Year Exclusive License and Distribution Agreement with J&H Co. LTD for Zestra for Female Sexual Arousal in South Korea [Daily Star, The (Lebanon)]
Zestra is currently exclusively partnered with Orimed Pharma in Canada, DanaLife in select European markets, Sothema Labs for the Middle East and North Africa, Elis Pharma in Turkey and certain select markets, Oz Biogenics for Myanmar and Vietnam, Biotask in Malaysia and non-exclusively to PT in Hong Kong and certain select Asian markets.
11/29/16 - Innovus Pharma Signs $2 Million a Year Exclusive License and Distribution Agreement with J&H Co. LTD for Zestra for Female Sexual Arousal in South Korea
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women s health and respiratory diseases, today announced the signing of an exclusive license and distribution agreement with J&H Co. LTD for t
11/29/16 - M Pharmaceutical Inc. Previews Business Strategy for Developing and Commercializing Prescription Strength C-103, Reformulated Orlistat
Vancouver, BC- M Pharmaceutical Inc.,, is providing a preview of the business strategy for the commercialization of its recently acquired C-103 Project. Orlistat is FDA- approved for weight management and sold by Roche as Xenical? and by GlaxoSmithKline as alli?. The drugs are not systemically absorbed, have strong safety profiles and are appro
11/29/16 - M Pharmaceutical Inc. Previews Business Strategy For Developing And Commercializing Prescription Strength C-103, Reformulated Orlistat [Arab News (Saudi Arabia)]
Orlistat is FDA- approved for weight management and sold by Roche as Xenical and by GlaxoSmithKline as alli. The drugs are not systemically absorbed, have strong safety profiles and are approved by the FDA. This approach is possible in light of the previous FDA approval for Rx Xenical in 1999..
11/29/16 - MonoSol Rx Submits New Drug Application for Tadalafil PharmFilm [New Dawn, The (Liberia)]
This application follows the successful completion of a pivotal pharmacokinetic study and a productive meeting with the FDA earlier this year, said Dan Barber, Vice President of MonoSol Rx. We believe that our product is well-positioned to compete in the multi-billion dollar erectile dysfunction market, based on its status as the first alternative
11/29/16 - Republican Policy Committee - First Steps in Obamacare Repeal and Replace
*Congress will keep its promise to the American people to repeal and replace Obamacare. *Last year, Congress passed a reconciliation bill that demonstrates how we can repeal the core parts of Obamacare with a transition to replace. Of those who are insured, many can't afford care due to sky-high deductibles, and most of the newly insured are insure
11/29/16 - Swine antibiotic requirement to change [Newton Daily News, Iowa]
According to the FDA, in 2012, the agency began issuing compliance policy guides regarding antibiotic usage in animal agriculture. This led to the FDA taking a new approach on the judicious use of medically important antibiotics in food-animal production. "The FDA implemented these guides in response to growing concern about antimicrobial resistan
Articles(s): 1 - 25 of 34     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415